Net Cash Provided by (Used in) Operating Activities |
-828K |
USD |
-6.61% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
300K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
2.17K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
213K |
USD |
-88.4% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Valuation Allowance |
644K |
USD |
+281% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Gross |
813K |
USD |
+381% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-644K |
USD |
-481% |
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Jun 30, 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2023 |
Q1 2023 |
Current Federal Tax Expense (Benefit) |
1.19M |
USD |
|
Dec 31, 2022 |
Q4 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jun 30, 2023 |
Q2 2023 |